Citations (63)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Nitish Kumar Mishra. (2011) Computational modeling of P450s for toxicity prediction. Expert Opinion on Drug Metabolism & Toxicology 7:10, pages 1211-1231.
Read now
Read now
Yuji Ishii, Shuso Takeda & Hideyuki Yamada. (2010) Modulation of UDP-glucuronosyltransferase activity by protein-protein association. Drug Metabolism Reviews 42:1, pages 145-158.
Read now
Read now
D. F. V. Lewis & Y. Ito. (2009) Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity. Xenobiotica 39:8, pages 625-635.
Read now
Read now
Grover P Miller. (2008) Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective. Expert Opinion on Drug Metabolism & Toxicology 4:8, pages 1053-1064.
Read now
Read now
A. Koike. (2006) Comparison of methods for chemical-compound affinity prediction. SAR and QSAR in Environmental Research 17:5, pages 497-514.
Read now
Read now
Olavi Pelkonen & Hannu Raunio. (2005) In vitro screening of drug metabolism during drug development: can we trust the predictions?. Expert Opinion on Drug Metabolism & Toxicology 1:1, pages 49-59.
Read now
Read now
U. Norinder. (2005)
In silico modelling of ADMET—a minireview of work from 2000 to 2004. SAR and QSAR in Environmental Research 16:1-2, pages 1-11.
Read now
Read now
David F. V. Lewis & Maruice Dickins. (2003) Baseline Lipophilicity Relationships in Human Cytochromes P450 Associated with Drug Metabolism. Drug Metabolism Reviews 35:1, pages 1-18.
Read now
Read now
Articles from other publishers (55)
David J. Ponting, Krista L. Dobo, Michelle O. Kenyon & Amit S. Kalgutkar. (2022)
Strategies for Assessing Acceptable Intakes for Novel
N
-Nitrosamines Derived from Active Pharmaceutical Ingredients
. Journal of Medicinal Chemistry 65:23, pages 15584-15607.
Crossref
Crossref
Filipa Lopes-Coelho, Filipa Martins, Ana Hipólito, Cindy Mendes, Catarina O. Sequeira, Rita F. Pires, António M. Almeida, Vasco D. B. Bonifácio, Sofia A. Pereira & Jacinta Serpa. (2021) The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy. Frontiers in Oncology 11.
Crossref
Crossref
Kiani, Ranaghan, Jabeen & Mulholland. (2019) Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors. International Journal of Molecular Sciences 20:18, pages 4468.
Crossref
Crossref
Alexander V. Dmitriev, Alexey A. Lagunin, Dmitry А. Karasev, Anastasia V. Rudik, Pavel V. Pogodin, Dmitry A. Filimonov & Vladimir V. Poroikov. (2019) Prediction of Drug-Drug Interactions Related to Inhibition or Induction of Drug-Metabolizing Enzymes. Current Topics in Medicinal Chemistry 19:5, pages 319-336.
Crossref
Crossref
Sayada Reemsha Kazmi, Ren Jun, Myeong-Sang Yu, Chanjin Jung & Dokyun Na. (2019) In silico approaches and tools for the prediction of drug metabolism and fate: A review. Computers in Biology and Medicine 106, pages 54-64.
Crossref
Crossref
Akifumi Eguchi, Masamichi Hanazato, Norimichi Suzuki, Yoshiharu Matsuno, Emiko Todaka & Chisato Mori. (2015) Maternal–fetal transfer rates of PCBs, OCPs, PBDEs, and dioxin-like compounds predicted through quantitative structure–activity relationship modeling. Environmental Science and Pollution Research 25:8, pages 7212-7222.
Crossref
Crossref
Jayalakshmi Sridhar, Navneet Goyal, Jiawang Liu & Maryam Foroozesh. (2017) Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date. Molecules 22:7, pages 1143.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
309
329
.
Yufeng J. Tseng, Bo-Han Su, Ming-Tsung Hsu & Olivia A. Lin. 2016. Frontiers in Molecular Design and Chemical Information Science - Herman Skolnik Award Symposium 2015: Jürgen Bajorath. Frontiers in Molecular Design and Chemical Information Science - Herman Skolnik Award Symposium 2015: Jürgen Bajorath
283
329
.
Manthena V. Varma, Stefanus J. Steyn, Charlotte Allerton & Ayman F. El-Kattan. (2015) Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS). Pharmaceutical Research 32:12, pages 3785-3802.
Crossref
Crossref
Bo-Han Su, Yi-shu Tu, Chieh Lin, Chi-Yu Shao, Olivia A. Lin & Yufeng J. Tseng. (2015) Rule-Based Prediction Models of Cytochrome P450 Inhibition. Journal of Chemical Information and Modeling 55:7, pages 1426-1434.
Crossref
Crossref
Syed Subhani & Kaiser Jamil. (2015) Molecular docking of chemotherapeutic agents to CYP3A4 in non-small cell lung cancer. Biomedicine & Pharmacotherapy 73, pages 65-74.
Crossref
Crossref
Roman Šink, Izidor Sosič, Matej Živec, Raquel Fernandez-Menendez, Samo Turk, Stane Pajk, Daniel Alvarez-Gomez, Eva Maria Lopez-Roman, Carolina Gonzales-Cortez, Joaquin Rullas-Triconado, Inigo Angulo-Barturen, David Barros, Lluís Ballell-Pages, Robert J. YoungLourdes Encinas & Stanislav Gobec. (2014) Design, Synthesis, and Evaluation of New Thiadiazole-Based Direct Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) for the Treatment of Tuberculosis. Journal of Medicinal Chemistry 58:2, pages 613-624.
Crossref
Crossref
Csilla Hegedüs, Tamás Hegedüs & Balázs Sarkadi. 2015. Resistance to Targeted ABC Transporters in Cancer. Resistance to Targeted ABC Transporters in Cancer
209
244
.
Oraphan Phuangsawai, Supa Hannongbua & Mathew Paul Gleeson. 2014. Drug Metabolism Prediction. Drug Metabolism Prediction
319
350
.
Kevin Beaumont, James R. Gosset & Chris E. Keefer. 2014. Predictive ADMET. Predictive ADMET
291
318
.
Thomas A. Dineen, Matthew M. Weiss, Toni Williamson, Paul Acton, Safura Babu-Khan, Michael D. Bartberger, James Brown, Kui Chen, Yuan Cheng, Martin Citron, Michael D. Croghan, Robert T. DunnIIII, Joel Esmay, Russell F. Graceffa, Scott S. Harried, Dean Hickman, Stephen A. Hitchcock, Daniel B. Horne, Hongbing Huang, Ronke Imbeah-Ampiah, Ted Judd, Matthew R. Kaller, Charles R. Kreiman, Daniel S. La, Vivian Li, Patricia Lopez, Steven Louie, Holger Monenschein, Thomas T. Nguyen, Lewis D. Pennington, Tisha San Miguel, E. Allen Sickmier, Hugo M. Vargas, Robert C. Wahl, Paul H. Wen, Douglas A. Whittington, Stephen Wood, Qiufen Xue, Bryant H. Yang, Vinod F. Patel & Wenge Zhong. (2012) Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors. Journal of Medicinal Chemistry 55:21, pages 9025-9044.
Crossref
Crossref
Jayalakshmi Sridhar, Jiawang Liu, Maryam Foroozesh & Cheryl L. Klein Stevens. (2012) Insights on Cytochrome P450 Enzymes and Inhibitors Obtained Through QSAR Studies. Molecules 17:8, pages 9283-9305.
Crossref
Crossref
Xuelin Zhou, Yan Wang, Penelope M.Y. Or, David C.C. Wan, Yiu Wa Kwan & John H.K. Yeung. (2012) Molecular docking and enzyme kinetic studies of dihydrotanshinone on metabolism of a model CYP2D6 probe substrate in human liver microsomes. Phytomedicine 19:7, pages 648-657.
Crossref
Crossref
Thomas Peyret & Kannan Krishnan. (2012) Quantitative Property-Property Relationship for Screening-Level Prediction of Intrinsic Clearance of Volatile Organic Chemicals in Rats and Its Integration within PBPK Models to Predict Inhalation Pharmacokinetics in Humans. Journal of Toxicology 2012, pages 1-22.
Crossref
Crossref
Benjamin C. Lewis, Peter I. Mackenzie & John O. Miners. (2011) Application of Homology Modeling to Generate CYP1A1 Mutants with Enhanced Activation of the Cancer Chemotherapeutic Prodrug Dacarbazine. Molecular Pharmacology 80:5, pages 879-888.
Crossref
Crossref
Rodrigo Santamaría, Lisa Rizzetto, Michael Bromley, Teresa Zelante, Wanseon Lee, Duccio Cavalieri, Luigina Romani, Brian Miller, Ivo Gut, Manuel Santos, Philippe Pierre, Paul Bowyer & Misha Kapushesky. (2011) Systems biology of infectious diseases: a focus on fungal infections. Immunobiology 216:11, pages 1212-1227.
Crossref
Crossref
Shahab Sheikh-Bahaei & C. Anthony Hunt. (2011) Enabling Clearance Predictions to Emerge from In Silico Actions of Quasi-Autonomous Hepatocyte Components. Drug Metabolism and Disposition 39:10, pages 1910-1920.
Crossref
Crossref
Xin Wang & John H.K. Yeung. (2011) Inhibitory effect of tanshinones on rat CYP3A2 and CYP2C11 activity and its structure-activity relationship. Fitoterapia 82:4, pages 539-545.
Crossref
Crossref
Yuu Shibano, Shiwori Taki, Aoi Miyamoto & Kazuo Uchikura. (2011) Development and Application of a Method to Investigate Drug-Metabolizing Enzyme Inhibitors Using Sparteine for Probe of Cytochrome P450 2D6 and Tris(2,2'-bipyridine)ruthenium(II)-Electrogenerated Chemiluminescence Detection. Chemical and Pharmaceutical Bulletin 59:2, pages 249-253.
Crossref
Crossref
Sean C Gay, Arthur G Roberts & James R Halpert. (2010) Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by x-ray crystallography and NMR. Future Medicinal Chemistry 2:9, pages 1451-1468.
Crossref
Crossref
Fahad I. Al-Jenoobi. (2010) Effects of some commonly used Saudi folk herbal medications on the metabolic activity of CYP2C9 in human liver microsomes. Saudi Pharmaceutical Journal 18:3, pages 167-171.
Crossref
Crossref
Dominique Lesuisse, Gilles Tiraboschi, Alain Krick, Pierre-Yves Abecassis, Gilles Dutruc-Rosset, Didier Babin, Frank Halley, Fabienne Châtreau, Sylvette Lachaud, Alain Chevalier, Dominique Quarteronet, Marie-Claude Burgevin, Céline Amara, Philippe Bertrand & Thomas Rooney. (2010) Design of potent and selective GSK3β inhibitors with acceptable safety profile and pharmacokinetics. Bioorganic & Medicinal Chemistry Letters 20:7, pages 2344-2349.
Crossref
Crossref
A. V. Veselovsky, B. N. Sobolev, M. S. Zharkova & A. I. Archakov. (2010) Computer-based substrate specificity prediction for cytochrome P450. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 4:1, pages 75-81.
Crossref
Crossref
Todd Ewing & Miklos Feher. (2010) Forecasting CYP2D6 and CYP3A4 Risk with a Global/Local Fusion Model of CYP450 Inhibition. Molecular Informatics 29:1-2, pages 127-141.
Crossref
Crossref
A.V. Veselovsky, B.N. Sobolev, M.S. Zharkova & A.I. Archakov. (2010) Computer-based substrate specifity prediction for cytochrome P450. Biomeditsinskaya Khimiya 56:1, pages 90-100.
Crossref
Crossref
Lisa Michielan, Lothar Terfloth, Johann Gasteiger & Stefano Moro. (2009) Comparison of Multilabel and Single-Label Classification Applied to the Prediction of the Isoform Specificity of Cytochrome P450 Substrates. Journal of Chemical Information and Modeling 49:11, pages 2588-2605.
Crossref
Crossref
Mingyue Zheng, Xiaomin Luo, Qiancheng Shen, Yong Wang, Yun Du, Weiliang Zhu & Hualiang Jiang. (2009) Site of metabolism prediction for six biotransformations mediated by cytochromes P450. Bioinformatics 25:10, pages 1251-1258.
Crossref
Crossref
Stefan Balaz. (2009) Modeling Kinetics of Subcellular Disposition of Chemicals. Chemical Reviews 109:5, pages 1793-1899.
Crossref
Crossref
David Boyer, Jonathan N. Bauman, Daniel P. Walker, Brendon Kapinos, Kapil Karki & Amit S. Kalgutkar. (2009)
Utility of MetaSite in Improving Metabolic Stability of the Neutral Indomethacin Amide Derivative and Selective Cyclooxygenase-2 Inhibitor 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1
H
-indol-3-yl)-
N
-phenethyl-acetamide
. Drug Metabolism and Disposition 37:5, pages 999-1008.
Crossref
Crossref
Aleksejs Kontijevskis, Jan Komorowski & Jarl E. S. Wikberg. (2008) Generalized Proteochemometric Model of Multiple Cytochrome P450 Enzymes and Their Inhibitors. Journal of Chemical Information and Modeling 48:9, pages 1840-1850.
Crossref
Crossref
Yuko Ito, Hiroki Kondo, Peter S. Goldfarb & David F.V. Lewis. (2008) Analysis of CYP2D6 substrate interactions by computational methods. Journal of Molecular Graphics and Modelling 26:6, pages 947-956.
Crossref
Crossref
M. Paul Gleeson, Andrew M. Davis, Kamaldeep K. Chohan, Stuart W. Paine, Scott Boyer, Claire L. Gavaghan, Catrin Hasselgren Arnby, Cecilia Kankkonen & Nan Albertson. (2007) Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models. Journal of Computer-Aided Molecular Design 21:10-11, pages 559-573.
Crossref
Crossref
Benjamin J. Davies, Janet K. Coller, Andrew A. Somogyi, Robert W. Milne & Benedetta C. Sallustio. (2007) CYP2B6, CYP2D6, and CYP3A4 Catalyze the Primary Oxidative Metabolism of Perhexiline Enantiomers by Human Liver Microsomes. Drug Metabolism and Disposition 35:1, pages 128-138.
Crossref
Crossref
Joseph O. Nwankwo. (2007) Significant transcriptional down-regulation of the human MDR1 gene by β-naphthoflavone: A proposed hypothesis linking potent CYP gene induction to MDR1 inhibition. Medical Hypotheses 68:3, pages 661-669.
Crossref
Crossref
Thomas Fox & Jan M. Kriegl. 2007.
63
81
.
Donald E. Mager. (2006) Quantitative structure–pharmacokinetic/pharmacodynamic relationships. Advanced Drug Delivery Reviews 58:12-13, pages 1326-1356.
Crossref
Crossref
P. Crivori & I. Poggesi. (2006) Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs. European Journal of Medicinal Chemistry 41:7, pages 795-808.
Crossref
Crossref
Peter Hlavica. (2006) Functional interaction of nitrogenous organic bases with cytochrome P450: A critical assessment and update of substrate features and predicted key active-site elements steering the access, binding, and orientation of amines. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1764:4, pages 645-670.
Crossref
Crossref
Harvey Wong, Scott J. Grossman, Stephen A. Bai, Sharon Diamond, Matthew R. Wright, James E. GraceJr.Jr., Mingxin Qian, Kan He, Krishnaswamy Yeleswaram & David D. Christ. (2004)
THE CHIMPANZEE (
PAN TROGLODYTES
) AS A PHARMACOKINETIC MODEL FOR SELECTION OF DRUG CANDIDATES: MODEL CHARACTERIZATION AND APPLICATION
. Drug Metabolism and Disposition 32:12, pages 1359-1369.
Crossref
Crossref
Konstantin V. Balakin, Sean Ekins, Andrey Bugrim, Yan A. Ivanenkov, Dmitry Korolev, Yuri V. Nikolsky, Andrey A. Ivashchenko, Nikolay P. Savchuk & Tatiana Nikolskaya. (2004)
QUANTITATIVE STRUCTURE-METABOLISM RELATIONSHIP MODELING OF METABOLIC
N
-DEALKYLATION REACTION RATES
. Drug Metabolism and Disposition 32:10, pages 1111-1120.
Crossref
Crossref
Konstantin V. Balakin, Sean Ekins, Andrey Bugrim, Yan A. Ivanenkov, Dmitry Korolev, Yuri V. Nikolsky, Andrey V. Skorenko, Andrey A. Ivashchenko, Nikolay P. Savchuk & Tatiana Nikolskaya. (2004) KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4. Drug Metabolism and Disposition 32:10, pages 1183-1189.
Crossref
Crossref
Kazuto Yamazaki & Masaharu Kanaoka. (2004) Computational prediction of the plasma protein‐binding percent of diverse pharmaceutical compounds. Journal of Pharmaceutical Sciences 93:6, pages 1480-1494.
Crossref
Crossref
Martin Payne. 2004. Predicting Chemical Toxicity and Fate. Predicting Chemical Toxicity and Fate.
David F.V. Lewis. (2004) Quantitative structure–activity relationships (QSARs) for substrates of human cytochromes P450 CYP2 family enzymes. Toxicology in Vitro 18:1, pages 89-97.
Crossref
Crossref
David F. V. Lewis. (2003) Quantitative structure–activity relationships (QSARs) within the cytochrome P450 system: QSARs describing substrate binding, inhibition and induction of P450s. InflammoPharmacology 11:1, pages 43-73.
Crossref
Crossref
D.F.V Lewis, B.G Lake, M.G Bird, G.D Loizou, M Dickins & P.S Goldfarb. (2003) Homology modelling of human CYP2E1 based on the CYP2C5 crystal structure: investigation of enzyme–substrate and enzyme–inhibitor interactions. Toxicology in Vitro 17:1, pages 93-105.
Crossref
Crossref
David F.V. Lewis, Maurice Dickins, Brian G. Lake & Peter S. Goldfarb. (2003) A MOLECULAR MODEL OF CYP2D6 CONSTRUCTED BY HOMOLOGY WITH THE CYP2C5 CRYSTALLOGRAPHIC TEMPLATE: INVESTIGATION OF ENZYME-SUBSTRATE INTERACTIONS. Drug Metabolism and Drug Interactions 19:3.
Crossref
Crossref
P. J. DabornJ. L. YenM. R. BogwitzG. Le GoffE. FeilS. JeffersN. TijetT. PerryD. HeckelP. BatterhamR. FeyereisenT. G. WilsonR. H. ffrench-Constant. (2002)
A Single P450 Allele Associated with Insecticide Resistance in
Drosophila
. Science 297:5590, pages 2253-2256.
Crossref
Crossref
D.F.V. Lewis, B.G. Lake, M. Dickins & P.S. Goldfarb. (2002) Molecular Modelling of CYP2B6 Based on Homology with the CYP2C5 Crystal Structure: Analysis of Enzyme-Substrate Interactions. Drug Metabolism and Drug Interactions 19:2.
Crossref
Crossref